Research ArticleNeuropharmacology
BCTP, a classic polymodal inhibitor of TRPV1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity
Mark S Nash, Peter McIntyre, Alex Groarke, Elliot Lilley, Andrew Culshaw, Allan Hallett, Moh Panesar, Alyson Fox and Stuart Bevan
Journal of Pharmacology and Experimental Therapeutics May 7, 2012, jpet.112.191932; DOI: https://doi.org/10.1124/jpet.112.191932
Mark S Nash
Peter McIntyre
Alex Groarke
Elliot Lilley
Andrew Culshaw
Allan Hallett
Moh Panesar
Alyson Fox
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNeuropharmacology
BCTP, a classic polymodal inhibitor of TRPV1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity
Mark S Nash, Peter McIntyre, Alex Groarke, Elliot Lilley, Andrew Culshaw, Allan Hallett, Moh Panesar, Alyson Fox and Stuart Bevan
Journal of Pharmacology and Experimental Therapeutics May 7, 2012, jpet.112.191932; DOI: https://doi.org/10.1124/jpet.112.191932
Research ArticleNeuropharmacology
BCTP, a classic polymodal inhibitor of TRPV1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity
Mark S Nash, Peter McIntyre, Alex Groarke, Elliot Lilley, Andrew Culshaw, Allan Hallett, Moh Panesar, Alyson Fox and Stuart Bevan
Journal of Pharmacology and Experimental Therapeutics May 7, 2012, jpet.112.191932; DOI: https://doi.org/10.1124/jpet.112.191932
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement